2025-02-01 2026-01-31 2026-01-31 false 15853761 THE HORMONE CLUB LTD 2026-07-07 86220 false iso4217:GBP xbrli:pure 15853761 2025-01-31 15853761 2026-01-31 15853761 2025-02-01 2026-01-31 15853761 2024-07-22 15853761 2025-01-31 15853761 2024-07-23 2025-01-31 15853761 bus:SmallEntities 2025-02-01 2026-01-31 15853761 bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 15853761 bus:FullAccounts 2025-02-01 2026-01-31 15853761 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 15853761 core:WithinOneYear 2026-01-31 15853761 core:AfterOneYear 2026-01-31 15853761 core:WithinOneYear 2025-01-31 15853761 core:AfterOneYear 2025-01-31 15853761 core:ShareCapital 2026-01-31 15853761 core:SharePremium 2026-01-31 15853761 core:RevaluationReserve 2026-01-31 15853761 core:OtherReservesSubtotal 2026-01-31 15853761 core:RetainedEarningsAccumulatedLosses 2026-01-31 15853761 core:ShareCapital 2025-01-31 15853761 core:SharePremium 2025-01-31 15853761 core:RevaluationReserve 2025-01-31 15853761 core:OtherReservesSubtotal 2025-01-31 15853761 core:RetainedEarningsAccumulatedLosses 2025-01-31 15853761 core:LandBuildings 2026-01-31 15853761 core:PlantMachinery 2026-01-31 15853761 core:Vehicles 2026-01-31 15853761 core:FurnitureFittings 2026-01-31 15853761 core:OfficeEquipment 2026-01-31 15853761 core:NetGoodwill 2026-01-31 15853761 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 15853761 core:ListedExchangeTraded 2026-01-31 15853761 core:UnlistedNon-exchangeTraded 2026-01-31 15853761 core:LandBuildings 2025-01-31 15853761 core:PlantMachinery 2025-01-31 15853761 core:Vehicles 2025-01-31 15853761 core:FurnitureFittings 2025-01-31 15853761 core:OfficeEquipment 2025-01-31 15853761 core:NetGoodwill 2025-01-31 15853761 core:IntangibleAssetsOtherThanGoodwill 2025-01-31 15853761 core:ListedExchangeTraded 2025-01-31 15853761 core:UnlistedNon-exchangeTraded 2025-01-31 15853761 core:LandBuildings 2025-02-01 2026-01-31 15853761 core:PlantMachinery 2025-02-01 2026-01-31 15853761 core:Vehicles 2025-02-01 2026-01-31 15853761 core:FurnitureFittings 2025-02-01 2026-01-31 15853761 core:OfficeEquipment 2025-02-01 2026-01-31 15853761 core:NetGoodwill 2025-02-01 2026-01-31 15853761 core:IntangibleAssetsOtherThanGoodwill 2025-02-01 2026-01-31 15853761 core:ListedExchangeTraded 2025-02-01 2026-01-31 15853761 core:UnlistedNon-exchangeTraded 2025-02-01 2026-01-31 15853761 core:MoreThanFiveYears 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments 2026-01-31 15853761 core:Non-currentFinancialInstruments 2025-01-31 15853761 dpl:CostSales 2025-02-01 2026-01-31 15853761 dpl:DistributionCosts 2025-02-01 2026-01-31 15853761 core:LandBuildings 2025-02-01 2026-01-31 15853761 core:PlantMachinery 2025-02-01 2026-01-31 15853761 core:Vehicles 2025-02-01 2026-01-31 15853761 core:FurnitureFittings 2025-02-01 2026-01-31 15853761 core:OfficeEquipment 2025-02-01 2026-01-31 15853761 dpl:AdministrativeExpenses 2025-02-01 2026-01-31 15853761 core:NetGoodwill 2025-02-01 2026-01-31 15853761 core:IntangibleAssetsOtherThanGoodwill 2025-02-01 2026-01-31 15853761 dpl:GroupUndertakings 2025-02-01 2026-01-31 15853761 dpl:ParticipatingInterests 2025-02-01 2026-01-31 15853761 dpl:GroupUndertakings core:ListedExchangeTraded 2025-02-01 2026-01-31 15853761 core:ListedExchangeTraded 2025-02-01 2026-01-31 15853761 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2025-02-01 2026-01-31 15853761 core:UnlistedNon-exchangeTraded 2025-02-01 2026-01-31 15853761 dpl:CostSales 2024-07-23 2025-01-31 15853761 dpl:DistributionCosts 2024-07-23 2025-01-31 15853761 core:LandBuildings 2024-07-23 2025-01-31 15853761 core:PlantMachinery 2024-07-23 2025-01-31 15853761 core:Vehicles 2024-07-23 2025-01-31 15853761 core:FurnitureFittings 2024-07-23 2025-01-31 15853761 core:OfficeEquipment 2024-07-23 2025-01-31 15853761 dpl:AdministrativeExpenses 2024-07-23 2025-01-31 15853761 core:NetGoodwill 2024-07-23 2025-01-31 15853761 core:IntangibleAssetsOtherThanGoodwill 2024-07-23 2025-01-31 15853761 dpl:GroupUndertakings 2024-07-23 2025-01-31 15853761 dpl:ParticipatingInterests 2024-07-23 2025-01-31 15853761 dpl:GroupUndertakings core:ListedExchangeTraded 2024-07-23 2025-01-31 15853761 core:ListedExchangeTraded 2024-07-23 2025-01-31 15853761 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-07-23 2025-01-31 15853761 core:UnlistedNon-exchangeTraded 2024-07-23 2025-01-31 15853761 core:NetGoodwill 2026-01-31 15853761 core:IntangibleAssetsOtherThanGoodwill 2026-01-31 15853761 core:LandBuildings 2026-01-31 15853761 core:PlantMachinery 2026-01-31 15853761 core:Vehicles 2026-01-31 15853761 core:FurnitureFittings 2026-01-31 15853761 core:OfficeEquipment 2026-01-31 15853761 core:AfterOneYear 2026-01-31 15853761 core:WithinOneYear 2026-01-31 15853761 core:ListedExchangeTraded 2026-01-31 15853761 core:UnlistedNon-exchangeTraded 2026-01-31 15853761 core:ShareCapital 2026-01-31 15853761 core:SharePremium 2026-01-31 15853761 core:RevaluationReserve 2026-01-31 15853761 core:OtherReservesSubtotal 2026-01-31 15853761 core:RetainedEarningsAccumulatedLosses 2026-01-31 15853761 core:NetGoodwill 2025-01-31 15853761 core:IntangibleAssetsOtherThanGoodwill 2025-01-31 15853761 core:LandBuildings 2025-01-31 15853761 core:PlantMachinery 2025-01-31 15853761 core:Vehicles 2025-01-31 15853761 core:FurnitureFittings 2025-01-31 15853761 core:OfficeEquipment 2025-01-31 15853761 core:AfterOneYear 2025-01-31 15853761 core:WithinOneYear 2025-01-31 15853761 core:ListedExchangeTraded 2025-01-31 15853761 core:UnlistedNon-exchangeTraded 2025-01-31 15853761 core:ShareCapital 2025-01-31 15853761 core:SharePremium 2025-01-31 15853761 core:RevaluationReserve 2025-01-31 15853761 core:OtherReservesSubtotal 2025-01-31 15853761 core:RetainedEarningsAccumulatedLosses 2025-01-31 15853761 core:NetGoodwill 2024-07-22 15853761 core:IntangibleAssetsOtherThanGoodwill 2024-07-22 15853761 core:LandBuildings 2024-07-22 15853761 core:PlantMachinery 2024-07-22 15853761 core:Vehicles 2024-07-22 15853761 core:FurnitureFittings 2024-07-22 15853761 core:OfficeEquipment 2024-07-22 15853761 core:AfterOneYear 2024-07-22 15853761 core:WithinOneYear 2024-07-22 15853761 core:ListedExchangeTraded 2024-07-22 15853761 core:UnlistedNon-exchangeTraded 2024-07-22 15853761 core:ShareCapital 2024-07-22 15853761 core:SharePremium 2024-07-22 15853761 core:RevaluationReserve 2024-07-22 15853761 core:OtherReservesSubtotal 2024-07-22 15853761 core:RetainedEarningsAccumulatedLosses 2024-07-22 15853761 core:AfterOneYear 2025-02-01 2026-01-31 15853761 core:WithinOneYear 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:CostValuation 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-02-01 2026-01-31 15853761 core:Non-currentFinancialInstruments core:CostValuation 2026-01-31 15853761 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2026-01-31 15853761 core:Non-currentFinancialInstruments core:CostValuation 2025-01-31 15853761 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-01-31 15853761 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-01-31 15853761 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-01-31 15853761 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-01-31 15853761 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-01-31 15853761 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-01-31 15853761 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-01-31 15853761 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-01-31 15853761 bus:Director1 2025-02-01 2026-01-31 15853761 bus:Director2 2025-02-01 2026-01-31 15853761 1 bus:Director1 2025-01-31 15853761 1 bus:Director1 2025-02-01 2026-01-31 15853761 1 bus:Director1 2026-01-31 15853761 2 bus:Director2 2025-01-31 15853761 2 bus:Director2 2025-02-01 2026-01-31 15853761 2 bus:Director2 2026-01-31 15853761 2025-01-31 15853761 2025-02-01 2026-01-31 15853761 2026-01-31

THE HORMONE CLUB LTD

Registered Number
15853761
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

THE HORMONE CLUB LTD
Company Information
for the year from 1 February 2025 to 31 January 2026

Directors | Dr Olivia Fahy-Browne
| Dr Patrick Fahy-Browne

Registered Address | 12a Trull Green Drive
| Trull
| Taunton
| TA3 7JL

Registered Number | 15853761 (England and Wales)

THE HORMONE CLUB LTD
Balance Sheet as at
31 January 2026

| Notes | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Intangible assets | 3 |  |  | 2,700 |  |  |  | -
|  |  |  | 2,700 |  |  |  | -
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 31,939 |  |  |  | 2 |  |
Cash at bank and on hand |  | 4,128 |  |  |  | - |  |
|  | 36,067 |  |  |  | 2 |  |
Creditors amounts falling due within one year | 5 | (13,950) |  |  |  | - |  |
Net current assets (liabilities) |  |  |  | 22,117 |  |  |  | 2
Total assets less current liabilities |  |  |  | 24,817 |  |  |  | 2
Net assets |  |  |  | 24,817 |  |  |  | 2
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 6 |  |  |  | 2
Profit and loss account |  |  |  | 24,811 |  |  |  | -
Shareholders' funds |  |  |  | 24,817 |  |  |  | 2

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 7 July 2026, and are signed on its behalf by:
Dr Patrick Fahy-Browne Director Registered Company No. 15853761

THE HORMONE CLUB LTD
Notes to the Financial Statements
for the year ended 31 January 2026

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Revenue from rendering of services
--- | ---
| Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

| Intangible assets
--- | ---
| Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.

| Goodwill
--- | ---
| Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.

2. | Average number of employees
--- | ---

|  | 2026 |  | 2025
| Average number of employees during the year | 2 |  | 2

3. | Intangible assets
--- | ---

|  | Goodwill |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 3,000 |  | 3,000
| At 31 January 26 | 3,000 |  | 3,000
| Amortisation and impairment
| Charge for year | 300 |  | 300
| At 31 January 26 | 300 |  | 300
| Net book value
| At 31 January 26 | 2,700 |  | 2,700
| At 31 January 25 | - |  | -

4. | Debtors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Other debtors | 31,939 |  | 2
| Total | 31,939 |  | 2

5. | Creditors: amounts due within one year
--- | ---

|  | 2026 |  | 2025
--- | --- | --- | --- | ---
|  | £ |  | £
| Taxation and social security | 13,950 |  | -
| Total | 13,950 |  | -

6. | Directors advances, credits and guarantees
--- | ---

|  | Brought forward |  | Amount advanced |  | Amount repaid |  | Carried forward
--- | --- | --- | --- | --- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
| Dr Olivia Fahy-Browne | 1 |  | 15,785 |  | 3,846 |  | 11,940
| Directors' loan account |  |  |  |  |  |  |
| Dr Patrick Fahy-Browne | 1 |  | 15,785 |  | 3,846 |  | 11,940
| Directors' loan account |  |  |  |  |  |  |
|  | 2 |  | 31,570 |  | 7,692 |  | 23,880